Sea Bird Medicare Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-07-2024
- Paid Up Capital ₹ 2.05 M
as on 03-07-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.80 M
as on 03-07-2024
- Revenue -29.00%
(FY 2023)
- Profit -60.03%
(FY 2023)
- Ebitda -51.18%
(FY 2023)
- Net Worth 13.69%
(FY 2023)
- Total Assets 12.14%
(FY 2023)
About Sea Bird Medicare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.05 M.
The company has closed loans amounting to ₹9.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sea Bird Medicare Private Limited India is Bobby Mathew as CEO. Bobby Mathew, Shyla Mathew, Jacob Mathew, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2010PTC205397
- Company No.
205397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2010
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sea Bird Medicare?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bobby Mathew  | CEO | 01-Apr-2015 | Current |
| Jacob Mathew | Managing Director | 12-Jul-2010 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyla Mathew | Whole-Time Director | 12-Jul-2010 | Current |
| Danny Mathew | Whole-Time Director | 07-Sep-2022 | Current |
| Doodh Singh | Director | 28-Nov-2014 | Current |
Financial Performance and Corporate Structure Insights of Sea Bird Medicare.
Sea Bird Medicare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29% decrease. The company also saw a substantial fall in profitability, with a 60.03% decrease in profit. The company's net worth Soared by an impressive increase of 13.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sea Bird Medicare?
In 2023, Sea Bird Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 05 Aug 2014 | ₹9.80 M | Satisfied |
How Many Employees Work at Sea Bird Medicare?
Sea Bird Medicare has a workforce of 43 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sea Bird Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sea Bird Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
